Ligand receives US$ 6.5 mn from Roche for progression of RG7348 into phase-I trial in treatment of HCV infection

Ligand receives US$ 6.5 mn from Roche for progression of RG7348 into phase-I trial in treatment of HCV infection
Ligand Pharmaceuticals Incorporated announced that it earned a US$ 6.5 million payment from Roche as a result of Roche progressing RG7348 into a phase-I clinical trial for the treatment of hepatitis C viral (HCV) infection.
Read more on [...]

Moderate drinking may slow arthritis progression

Moderate drinking may slow arthritis progression
NEW YORK (Reuters Health) – Some studies have suggested that moderate drinkers have a lower risk of developing rheumatoid arthritis, and now new findings link the habit to a slower progression of the joint disease.
Read more on Reuters

New data shows early treatment with etanercept/methotrexate combo can prevent RA progression

New data shows early treatment with etanercept/methotrexate combo can prevent RA progression
New data from the COMET trial, published in Arthritis & Rheumatism,demonstrate that combination therapy with etanercept and methotrexate over two years achieved radiographic remission (i) in 90 per cent of evaluable subjects with early active rheumatoid arthritis (RA), (1) The results also showed that [...]